Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Frequency of Ipsilateral Axillary Lymphadenopathy After the Inactivated COVID-19 Vaccine

Author(s): Aynur Turan*, Hatice Kaplanoğlu and Veysel Kaplanoğlu

Volume 18, Issue 11, 2022

Published on: 29 April, 2022

Article ID: e100322202019 Pages: 8

DOI: 10.2174/1573405618666220310115711

Price: $65

Abstract

Objective: During COVID-19 vaccine development studies, vaccines' efficacy and safety profiles should be carefully investigated. Only a few studies have shown that the COVID-19 vaccine can cause axillary lymphadenopathy on the injection arm. This study aimed to investigate the incidence of axillary lymphadenopathy and imaging findings using B-mode and Doppler ultrasonography (US) examinations in volunteers who had recently been vaccinated against COVID-19.

Methods: The ipsilateral and contralateral axillae of 101 volunteers who received the COVID-19 vaccine were evaluated using B-mode and Doppler US examinations. The volunteers were asked when and to which arm the vaccine had been applied, and the type and dose of the vaccine were recorded. It was also questioned whether the individual experienced any side effects after vaccination, such as pain, tenderness, fever, and redness at the injection site. In addition, the demographic data of the participants, such as age and gender, were recorded.

Results: The B-mode US examinations revealed that the long- and short-axis diameters, size, cortical thickness, and asymmetric cortical thickening of the left axillary lymph nodes were significantly higher compared to the right side in individuals having received the CoronaVac vaccine (p<0.05). When the individuals were evaluated separately according to gender, the frequency of cortical thickness and asymmetric cortical thickening in the left axillary lymph nodes was higher than on the right side in both males and females (p=0.011).

Conclusion: It should be kept in mind that ipsilateral reactive lymphadenopathy may develop after the COVID-19 vaccine. This knowledge can prevent unnecessary axillary lymph node biopsies.

Keywords: COVID-19, CoronaVac vaccine, vaccine, ultrasound, ipsilateral, axillary lymphadenopathy, B-mode US examinations.

Graphical Abstract

[1]
WHO. 2020.COVID-19 Dashboard. Geneva: World Health Organization Available from: https://covid19.who.int/ [Accessed on: 2021, April 5].
[2]
Kwok KO, Lai F, Wei WI, Wong SY, Tang JW. Herd immunity–estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect 2020; 80(6): e32-3.
[http://dx.doi.org/10.1016/j.jinf.2020.03.027]
[3]
Mortazavi S. COVID-19 vaccination-associated axillary adenopathy: Imaging findings and follow-up recommendations in 23 women. AJR Am J Roentgenol 2021; 217(4): 857-8.
[http://dx.doi.org/10.2214/AJR.21.25651] [PMID: 33624520]
[4]
Granata V, Fusco R, Setola SV, et al. Lymphadenopathy after BNT162b2 Covid-19 vaccine: Preliminary ultrasound findings. Biology (Basel) 2021; 10(3): 214.
[5]
Özütemiz C, Krystosek LA, Church AL, et al. Lymphadenopathy in COVID-19 vaccine recipients: Diagnostic dilemma in oncologic pa-tients. Radiology 2021; 300(1): E296-300.
[http://dx.doi.org/10.1148/radiol.2021210275] [PMID: 33625300]
[6]
Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of corona-virus disease (COVID-19) vaccination. AJR Am J Roentgenol 2021; 217(4): 831-4.
[http://dx.doi.org/10.2214/AJR.21.25604] [PMID: 33543649]
[7]
Radiopaedia.org. Available from: https://radiopaedia.org/articles/sonographic-featuresof-malignant-lymph-nodes
[8]
Kumar P, Erturk VS, Murillo-Arcila M. A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys 2021; 24: 104213.
[http://dx.doi.org/10.1016/j.rinp.2021.104213] [PMID: 33898210]
[9]
McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 vaccination-related uptake on FDG PET/CT: An emerging dilemma and suggestions for management. AJR Am J Roentgenol 2021; 217(4): 975-83.
[http://dx.doi.org/10.2214/AJR.21.25728] [PMID: 33646823]
[10]
Thomassen A, Lerberg Nielsen A, Gerke O, Johansen A, Petersen H. Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination. Eur J Nucl Med Mol Imaging 2011; 38(5): 894-8.
[http://dx.doi.org/10.1007/s00259-011-1729-9] [PMID: 21340453]
[11]
Shirone N, Shinkai T, Yamane T, et al. Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination. Ann Nucl Med 2012; 26(3): 248-52.
[http://dx.doi.org/10.1007/s12149-011-0568-x] [PMID: 22271546]
[12]
Local reactions, systemic reactions, adverse events, and serious adverse events: Moderna COVID-19 vaccine, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention. 2020. Available from: www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html [Accessed on: 20 Dec. 2020].
[13]
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383(27): 2603-15.
[http://dx.doi.org/10.1056/NEJMoa2034577] [PMID: 33301246]
[14]
Local reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 vaccine, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention. 2020. Available from: www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html [Accessed on: 13 Dec. 2020].
[15]
Li T, Zhang T, Gu Y, Li S, Xia N. Current progress and challenges in the design and development of a successful COVID-19 vaccine. Fun-damental Research 2021; 1(2): 139-50.
[http://dx.doi.org/10.1016/j.fmre.2021.01.011]
[16]
Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021; 21(2): 181-92.
[http://dx.doi.org/10.1016/S1473-3099(20)30843-4] [PMID: 33217362]
[17]
Mehta N, Sales RM, Babagbemi K, et al. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine. Clin Imaging 2021; 75: 12-5.
[http://dx.doi.org/10.1016/j.clinimag.2021.01.016] [PMID: 33486146]

Rights & Permissions Print Cite
Article Metrics
19
© 2024 Bentham Science Publishers | Privacy Policy